Manulife (Manufacturers Life Insurance)’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-23,422
| Closed | -$900K | – | 3041 |
|
|
2023
Q2 | $900K | Buy |
23,422
+3,137
| +15% | +$80.6K | ﹤0.01% | 1715 |
|
|
2023
Q1 | $470K | Buy |
20,285
+908
| +5% | +$21.6K | ﹤0.01% | 2043 |
|
|
2022
Q4 | $508K | Buy |
19,377
+2,244
| +13% | +$49.7K | ﹤0.01% | 1980 |
|
|
2022
Q3 | $337K | Sell |
17,133
-477
| -3% | -$9.57K | ﹤0.01% | 2228 |
|
|
2022
Q2 | $308K | Buy |
17,610
+751
| +4% | +$11.8K | ﹤0.01% | 2378 |
|
|
2022
Q1 | $276K | Sell |
16,859
-3,436
| -17% | -$46.7K | ﹤0.01% | 2563 |
|
|
2021
Q4 | $331 | Buy |
20,295
+559
| +3% | +$7.96K | ﹤0.01% | 2540 |
|
|
2021
Q3 | $252K | Buy |
19,736
+919
| +5% | +$12.1K | ﹤0.01% | 2805 |
|
|
2021
Q2 | $266K | Buy |
+18,817
| New | +$301K | ﹤0.01% | 2907 |
|
|
2020
Q4 | – | Sell |
-8,684
| Closed | -$106K | – | 3040 |
|
|
2020
Q3 | $106K | Hold |
8,684
| – | – | ﹤0.01% | 2783 |
|
|
2020
Q2 | $97K | Buy |
8,684
+797
| +10% | +$11K | ﹤0.01% | 2766 |
|
|
2020
Q1 | $108K | Buy |
+7,887
| New | +$93.3K | ﹤0.01% | 2563 |
|
|
2019
Q2 | – | Sell |
-8,804
| Closed | -$175K | – | 2974 |
|
|
2019
Q1 | $175K | Buy |
8,804
+162
| +2% | +$2.83K | ﹤0.01% | 2477 |
|
|
2018
Q4 | $115K | Sell |
8,642
-432
| -5% | -$8.63K | ﹤0.01% | 2422 |
|
|
2018
Q3 | $334K | Sell |
9,074
-991
| -10% | -$31.8K | ﹤0.01% | 2494 |
|
|
2018
Q2 | $351K | Buy |
10,065
+2,850
| +40% | +$109K | ﹤0.01% | 2669 |
|
|
2018
Q1 | $335K | Sell |
7,215
-144
| -2% | -$5.27K | ﹤0.01% | 2629 |
|
|
2017
Q4 | $276K | Buy |
7,359
+313
| +4% | +$13.7K | ﹤0.01% | 2765 |
|
|
2017
Q3 | $375K | Buy |
7,046
+253
| +4% | +$15K | ﹤0.01% | 2482 |
|
|
2017
Q2 | $388K | Buy |
6,793
+754
| +12% | +$37.8K | ﹤0.01% | 2486 |
|
|
2017
Q1 | $324K | Buy |
6,039
+713
| +13% | +$40.3K | ﹤0.01% | 2492 |
|
|
2016
Q4 | $303K | Buy |
5,326
+149
| +3% | +$9.01K | ﹤0.01% | 2468 |
|
|
2016
Q3 | $321K | Sell |
5,177
-14
| -0.3% | -$990 | ﹤0.01% | 2410 |
|
|
2016
Q2 | $294K | Buy |
5,191
+3,739
| +258% | +$227K | ﹤0.01% | 2407 |
|
|
2016
Q1 | $88K | Buy |
1,452
+10
| +0.7% | +$809 | ﹤0.01% | 3101 |
|
|
2015
Q4 | $203 | Buy |
1,442
+29
| +2% | +$3.94K | ﹤0.01% | 2655 |
|
|
2015
Q3 | $137 | Buy |
1,413
+43
| +3% | +$5.12K | ﹤0.01% | 2961 |
|
|
2015
Q2 | $207 | Buy |
+1,370
| New | +$226K | ﹤0.01% | 2821 |
|
Manulife (Manufacturers Life Insurance)'s KDNY Position: Q3 2023 in Review
Manulife (Manufacturers Life Insurance) sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 23,422 shares — an estimated $900K sold.
Manulife (Manufacturers Life Insurance) first reported a position in KDNY in Q2 2015 and held it in 28 quarters. The position peaked at $900K in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.
- Manulife (Manufacturers Life Insurance) reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 23,422 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $900K.
- Manulife (Manufacturers Life Insurance) first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2015 and held it in 28 quarters.
- Manulife (Manufacturers Life Insurance)'s Chinook Therapeutics, Inc. Common Stock position peaked at $900K in Q2 2023.
- 2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2023, filed 15 Nov 2023.